2021年11月22日，上海慧晓律师事务所主任和中美执业律师谢晓云受邀参加由以下主办方和协办方在上海生物与医药创新孵化园多功能厅成功举办的《携手迈进美国FDA-人工智能医疗器械法规与申报研讨会》（三名主讲者），并为来自中国（包括大陆、香港、台湾等）境内外医疗器械公司、私募基金、医疗器械申报代理、以及其他专业研究人员和专业人员分享和主讲《中国法框架下人工智能医疗器械产品之法律合规要点分析及对策探讨》，并获得与会听众的一致好评。

此活动主办方：上海市生物医药科技发展中心
此活动协办方：

    1、维州生物科技股份有限公司
    2、汇智赢华医疗科技研发有限公司
    3、上海慧晓律师事务所
    4、上海张江创新学院
    5、上海张江药谷公共服务平台有限公司

On 22 Nov 2021, Ms. Ellen Xie (Lawyer Admitted in China and US), Managing Director of Shanghai Hui Xiao Law Group was invited to attend the US FDA Artificial Intelligence Medical Device Regulatory Affairs and Registration Seminar at Shanghai Biological and Pharmaceutical Innovation Incubation Park sponsored by the following entities, and provided a training on the Practical Solutions for Solving Key Legal and Compliance Issues Associated with Artificial Intelligence Medical Device Industry under PRC Law to medical devices companies, private equity funds, FDA reporting agents and other researchers and professionals coming from China and outside of China, and received good feedback from the audience.

Sponsor of the Event: Shanghai Biomedical Technology Development Center

Co-Sponsors of the Event:

    1.Virginia Contract Research Organization Co., Ltd. (VCRO)
    2.Gateway Medical Innovation Center (Gateway)
    3.Shanghai Hui Xiao Law Group (HUIXIAOLAW)
    4.Shanghai Zhangjiang Innovation College
    5.Shanghai Zhangjiang Pharmaceutical Valley Public Service Platform Co., Ltd.